Who has invested in Incyclix Bio?

Eshelman Ventures, Eli Lilly and Company, Pharmacosmos, Cape Fear BioCapital are named among the investors backing Incyclix Bio.

Incyclix Bio Funding: $11M Raised, Series B (2025)

Incyclix Bio funding overview

Incyclix Bio is based in Durham. Incyclix Bio has raised $11M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in August 2025. The round record for Incyclix Bio runs through 2025; nothing later has been disclosed. Investors on record include Eshelman Ventures, Eli Lilly and Company, Pharmacosmos, Cape Fear BioCapital. 4 distinct backers are named across the disclosed rounds.

Incyclix Bio at a glance

Total raised: $11M
Latest round: Series B
Latest round date: August 2025
Headquarters: Durham
Notable investors: Eshelman Ventures, Eli Lilly and Company, Pharmacosmos, Cape Fear BioCapital

Frequently asked about Incyclix Bio funding

How much has Incyclix Bio raised?: Incyclix Bio has raised $11M in total disclosed funding across the rounds on record.
Who has invested in Incyclix Bio?: Eshelman Ventures, Eli Lilly and Company, Pharmacosmos, Cape Fear BioCapital are named among the investors backing Incyclix Bio.
What was the latest Incyclix Bio funding round?: The most recent disclosed round is a Series B, announced in August 2025.
Where is Incyclix Bio based?: Incyclix Bio is based in Durham.
When did Incyclix Bio last raise?: The last disclosed Incyclix Bio round closed in August 2025 at Series B.

We update the Incyclix Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Durham and their backers are listed below.

Incyclix Bio Funding: $11M Raised, Series B (2025)

Incyclix Bio funding overview

Incyclix Bio at a glance

Frequently asked about Incyclix Bio funding

Companies related to Incyclix Bio (21)

Browse related funding lists (4)